Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Kyorin designs new series of potent, selective and orally active human PPARalpha activators

Dec. 2, 2002

Japan Tobacco presents new inhibitors of hematopoietic cell phosphatase

Dec. 2, 2002

Novel beta3-adrenoceptor agonists for obesity, diabetes, etc.

Dec. 2, 2002

P&G discovers series of melanocortin MC3/MC4 ligands

Dec. 2, 2002

Novel insulin mimetics from plant origin described by Suntory

Dec. 2, 2002

Antidiabetic efficacy of GLP-1 derivative NN-2211 in minipigs

Dec. 2, 2002

Wyeth presents new oxytocin antagonists with potential as tocolytic agents

Nov. 29, 2002

Disappointing preliminary data and negative complete response letter for Replagal

Nov. 29, 2002

Teriparatide more effective than alendronate in postmenopausal osteoporosis

Nov. 29, 2002

Teriparatide approved by the FDA to treat osteoporosis

Nov. 28, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...